期刊文献+

螺旋CT三维定量测量评估I期非小细胞肺癌肿瘤大小及T分期的价值 被引量:7

Three-dimensional Quantitative Measurement of Spiral CT in Evaluating Tumor Size and T Stage of Stage I Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的探讨螺旋CT三维定量测量评估I期非小细胞肺癌(NSCLC)肿瘤最大径及术前T分期的价值。资料与方法 125例经手术病理证实的I期NSCLC患者,均有完整的CT检查资料,评估CT三维定量测量与二维测量、大体病理测量肿瘤最大径及T分期的差异。结果 CT三维定量测量、二维测量及大体病理测量125例患者的肿瘤平均最大径分别为(26.21±8.14)mm、(27.03±9.90)mm、(25.60±9.31)mm;二维测量与三维定量测量、大体病理测量肿瘤最大径差异均有统计学意义(t=2.377,P<0.05;t=2.961,P<0.01),三维定量测量与大体病理测量肿瘤最大径差异无统计学意义(t=1.281,P>0.05);Bland-Altman分析显示,以大体病理测量结果作为"金标准",三维定量测量较二维测量一致性更高;在此基础上,以三维定量测量结果为对照,有25例(20%)二维测量分期结果与其不一致。结论螺旋CT三维定量测量对I期NSCLC肿瘤最大径测量及术前分期结果较二维测量更准确,可以为NSCLC患者术前分期、评估预后和疗效提供更准确的评价标准。 Purpose To investigate the value of three-dimensional quantitative measurement of spiral CT in evaluating tumor size and preoperative T stage in stage 1 non-small cell lung cancer (NSCLC). Materials and Methods The complete data of 125 patients with stage I NSCLC confirmed surgically and pathologically were compared in terms of maximum tumor diameter and T stage analysis by means of three-dimensional quantitative CT measurement, two-dimensional measurement and general pathology measurement. Results The mean maximum tumor diameter of these 125 patients measured by quantitative three-dimensional CT measurement two-dimensional measurement and general pathology measurement were (26.21 ± 8.14) mm, (27.03 ± 9.90) mm and (25,60±9.31) mm, respectively. The difference in mean maximum tumor diameter by two-dimensional measurement and three-dimensional quantitative measurement was significant, and remained so when two-dimensional measurement and pathology measurement was compared (t=-2.377, P〈0.05; t=2.961, P〈0.01), but that between three- dimensional quantitative measurement and pathology measurement was not significant (t=1.281, P〉0.05). Bland-Altman analysis showed that three-dimensional quantitative measurement had higher consistency than two-dimensional measurement when compared with the gold standard pathology measurement. When three-dimensional quantitative measurement was taken to be the staging criterion, 20% results (25 cases) obtained by two-dimensional measurement proved to be inconsistent. Conclusion Compared with two-dimensional measurement, quantitative three-dimensional CT measurement can provide more accurate information in maximum tumor diameter and T stage for patients with stage 1 NSCLC, theretbre can be applied as a more accurate criterion in preoperative staging and prognosis of stage I NSCLC.
出处 《中国医学影像学杂志》 CSCD 北大核心 2013年第12期899-902,共4页 Chinese Journal of Medical Imaging
基金 广东省医学科研基金项目(A2010237)
关键词 非小细胞肺 体层摄影术 螺旋计算机 成像 三维 肿瘤分期 Carcinoma, non-small-cell lung Tomography, spiral computed Imaging, three-dimensional Neoplasm staging
  • 相关文献

参考文献13

  • 1Rami-Porta R, Crowley J J, Goldstraw P. The revised TNM staging system tbr lung cancer. Ann Thorac Cardiovasc Surg, 2009, 15(1): 4-9.
  • 2Marten K, Auer F, Schmidt S, et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur Radiol, 2006, 16(4): 781-790.
  • 3Revel MP, Bissery A, Bienvenu M, et al. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology, 2004, 231(2): 453-458.
  • 4Jennings SG, Winer-Muram HT, Tarver RD, et al. Lung tumor growth: assessment with CT--comparison of diameter and cross-sectional area with volume measurements. Radiology, 2004, 231 (3): 866-871.
  • 5Yankelevitz DF, Reeves AP, Kostis W J, et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology, 2000, 217(1 ): 251-256.
  • 6Revel MP, Lefort C, Bissery A, et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology, 2004, 231 (2): 459-466.
  • 7Pfannschmidt J, Muley T, Btilzebruck H, et al. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer, 2007, 55(3): 371-377.
  • 8Schneider BJ. Non-small cell lung cancer staging: proposed revisions to the TNM system. Cancer Imaging, 2008, 8(8): 181-185.
  • 9Zhao B, Schwartz LH, Moskowitz CS, et al. Lung cancer: computerized quantification of tumor response-initial results. Radiology, 2006, 241 (3): 892-898.
  • 10Belton AL, Saini S, Liebermann K, et al. Tumour size measurement in an oncology clinical trial: comparison between off-site and on-site measurements. Clin Radiol. 2003, 58(4): 311-314.

二级参考文献54

  • 1林丽珠,陶志广,周岱翰.WHO标准和RECIST在肺癌多中心疗效评价的比较[J].中国肿瘤临床,2006,33(5):253-255. 被引量:41
  • 2Revel MP , Bissery A , Bienvenu M , et al . Are two - dimensional CT measurements of small noncalcified pulmonary nodules reliable? [J]. Radiology ,2004 ,231 (2) :453-458.
  • 3Jennings SG, Winer - Muram HT, Tarver RD, et al. Lung tumor growth : assessment with CT - comparison of diameter and cross - sectional area with volume measurements [ J]. Radiology, 2004, 231 (3) :866 -871.
  • 4Yankelevitz DF, Reeves AP, Kostis WJ,et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation [ J ]. Radiology ,2000,217 ( 1 ) :251 - 256.
  • 5Revel MP, Lefort C , Bissery A , et al. Pulmonary nodules: preliminary experience with three dimensional evaluation [ J ]. Radiology, 2004,231 (2) :459 -466.
  • 6Halligan S. Reproducibility, repeatability, correlation and measurement error[J]. Br J Radiol,2002, 75 (890) :193 - 194, 194 -195.
  • 7Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement [ J ]. Lancet, 1986,1 (8476) :307 - 310.
  • 8Ko JP , Rusinek H , Jacobs EL , et al . Small pulmonary nodules: volume measurement at chest CT phantom study [ J ]. Radiology, 2003,228 (3) :864-870.
  • 9Yankelevitz DF, Reeves AP, Kostis WJ,et al. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation [ J]. Radiology ,2000, 217 ( 1 ) :251 - 256.
  • 10Revel MP, Lefort C , Bissery A , et al. Pulmonary nodules: preliminary experience with three dimensional evaluation [ J ]. Radiology, 2004,231 (2) :459 -466.

共引文献79

同被引文献64

  • 1杨苏慧,钱永红.三维适形放疗同步化疗治疗局部晚期非小细胞肺癌临床观察[J].中国医师进修杂志,2011,34(S01):19-20. 被引量:4
  • 2杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学,2004,4(2):85-90. 被引量:1479
  • 3李智勇,伍建林,李光军,王克礼,刘晓峰.多层CT灌注成像在肺癌TNM分期中的初步临床研究[J].实用放射学杂志,2007,23(1):54-56. 被引量:14
  • 4KangH, Lee HY, Lee KS, et al. Imaging-based tumor treatmentresponse evaluation: Review of conventional, new, and emergingconcepts. Korean J Radiol, 2012,13(4) :371-390.
  • 5Erasmus JJ, Gladish GW, Broemeling L, et al. Interobserver andintraobserver variability in measurement of non-small-cell carcino-ma lung lesions: Implications for assessment of tumor response. JClin Oncol, 2003,21(13):2574-2582.
  • 6Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelinesto evaluate the response to treatment in solid tumors. EuropeanOrganization for Research and Treatment of Cancer, NationalCancer Institute of the United States, National Cancer Institute ofCanada. J Natl Cancer Inst, 2000, 92(3) : 205-216.
  • 7Firmino M, Morais AH, Mendoca RM, et al. Computer-aideddetection system for lung cancer in computed tomography scans:Review and future prospects. Biomed Eng Online, 2014,13:41.
  • 8Gietema HA, Wang Y, Xu D, et al. Pulmonary nodules detectedat lung cancer screening : Interobserver variability of semiauto-mated volume measurements. Radiology, 2006,241(1) :251-257.
  • 9Henschke Cl, Yankelevitz DF,Yip R, et al. Lung cancers diag-nosed at annual CT screening: Volume doubling times. Radiolo-gy, 2012,263(2):578-583.
  • 10Revel MP, Merlin A, Peyrard S, et al. Software volumetricevaluation of doubling times for differentiating benign versus ma-lignant pulmonary nodules. AJR Am J Roentgenol, 2006,187(1):135-142.

引证文献7

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部